Single-cell RNA sequencing (scRNA-seq) of circulating tumor cells (CTCs) treated with OC should map shifts in the TNF-α–NF-κB–IL-8 axis, elucidating OC’s capacity to mitigate pro-metastatic signaling trajectories. This evidence concerns the gene NFKB1 and neoplasm.